Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FHL2 Antikörper

FHL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2763848
  • Target Alle FHL2 Antikörper anzeigen
    FHL2 (Four and A Half LIM Domains 2 (FHL2))
    Reaktivität
    • 43
    • 31
    • 17
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 34
    • 8
    • 2
    Kaninchen
    Klonalität
    • 29
    • 14
    Polyklonal
    Konjugat
    • 26
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser FHL2 Antikörper ist unkonjugiert
    Applikation
    • 25
    • 11
    • 9
    • 9
    • 6
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Kreuzreaktivität
    Human
    Produktmerkmale
    Four-and-a-half LIM only protein 2, FHL2,Sphingosine kinase-1 (SK1) is a key enzyme that catalyzes the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). SK1, and its product S1P, regulate numerous and diverse biological functions, including cell growth, differentiation, proliferation, and apoptosis. S1P also plays a central role in cardiac development and ischemic preconditioning. FHL2 (SLIM3) has been identified as a SK1-interacting protein in mammalian cardiomyocytes. FHL2, but not FHL1 or FHL3, interacts with SK1, and FHL2 colocalizes with SK1 in the cytoplasm of these cells. The interaction of FHL2 with SK-1 involves the C-terminal portion of SK1. Overexpression of FHL2 has been found to attneuate the activity and antiapoptotic effects of SK1. Endothelin-1, a potent survival factor in cardiomyocytes, inhibits FHL2-SK1 association and increases SK1 activity. FHL2 is therefore a novel inhibitor of SK1 activity in cardiomyocytes and targeting FHL2 may prevent myocardial apoptosis through activation of SK1. A transcriptional coactivator, FHL2 is also known to form complexes consisting of Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1), FHL2, and androgen receptors (AR) in prostate cancer cells, perhaps functioning as a molecular adaptor with PELP1 in the progression of prostate cancer.
    Aufreinigung
    Antigen Immunoaffiinity Purification
    Immunogen
    Synthetic peptide derived from the human FHL2 protein
    Isotyp
    IgG
    Top Product
    Discover our top product FHL2 Primärantikörper
  • Applikationshinweise
    Antibody can be used for Western blotting (0.5-2 μg/mL). Also binds ABB73038, FHL2 isoform 5 with MW of 389 a.a. (~42 kDa). Optimal concentration should be evaluated by serial dilutions.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    Lot specific
    Buffer
    Provided as ligand affinity purified antibody in phosphate buffered saline with 0.08 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -80 °C
    Informationen zur Lagerung
    Product should be stored at -70°C. Aliquot to avoid freeze/thaw cycles
  • Target
    FHL2 (Four and A Half LIM Domains 2 (FHL2))
    Andere Bezeichnung
    FHL2 (FHL2 Produkte)
    Synonyme
    AAG11 antikoerper, DRAL antikoerper, FHL-2 antikoerper, SLIM-3 antikoerper, SLIM3 antikoerper, C76204 antikoerper, FHL2 antikoerper, zgc:92428 antikoerper, zgc:103466 antikoerper, four and a half LIM domains 2 antikoerper, four and a half LIM domains 2a antikoerper, four and a half LIM domains 2b antikoerper, FHL2 antikoerper, Fhl2 antikoerper, fhl2 antikoerper, fhl2a antikoerper, fhl2b antikoerper
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
Kundenservice